Beranda › Kanker Paru Sel Kecil › Pennsylvania › Pittsburgh
Uji klinis Kanker Paru Sel Kecil di Pittsburgh, PA
5 studi untuk Kanker Paru Sel Kecil mencari peserta di lokasi sekitar Pittsburgh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Menerima pesertaFase 3
- AHN Cancer Institute - Allegheny General, Pittsburgh
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Menerima pesertaFase 3
- Allegheny General Hospital, Pittsburgh
- University of Pittsburgh (UPMC) Hillman Cancer Center, Pittsburgh
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Menerima pesertaFase 2
- UPMC Hillman Cancer Center, Pittsburgh
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Menerima pesertaFase 1/2
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Uji klinis Kanker Paru Sel Kecil di kota lain
- Houston, TX26 studi
- Arlington, VA23 studi
- Boston, MA21 studi
- New York City, NY21 studi
- Nashville, TN20 studi
- Los Angeles, CA20 studi
- Orlando, FL15 studi
- Dallas, TX13 studi
- St. Louis, MO13 studi
- Cleveland, OH13 studi
- Detroit, MI12 studi
- Chicago, IL12 studi
Studi lain di Pittsburgh
- Kanker Paru Non-Sel Kecil48 studi
- Kanker (semua jenis)41 studi
- Kanker Payudara39 studi
- Kanker Kolorektal32 studi
- Kanker Metastatik31 studi
- Melanoma31 studi
- Kanker Ovarium30 studi
- Kanker Endometrium23 studi
- Kanker Paru23 studi
- Kanker Prostat23 studi
- Stroke22 studi
- Karsinoma Sel Skuamosa Kepala dan Leher22 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.